l e t t e r s Allergic disease is very common and carries substantial public-health burdens. We conducted a meta-analysis of genome-wide associations with self-reported cat, dust-mite and pollen allergies in 53,862 individuals. We used generalized estimating equations to model shared and allergy-specific genetic effects. We identified 16 shared susceptibility loci with association P < 5 × 10 −8 , including 8 loci previously associated with asthma, as well as 4p14 near TLR1, TLR6 and TLR10 (rs2101521, P = 5.3 × 10 −21 ); 6p21.33 near HLA-C and MICA (rs9266772, P = 3.2 × 10 −12 ); 5p13.1 near PTGER4 (rs7720838, P = 8.2 × 10 −11 ); 2q33.1 in PLCL1 (rs10497813, P = 6.1 × 10 −10 ), 3q28 in LPP (rs9860547, P = 1.2 × 10 −9 ); 20q13.2 in NFATC2 (rs6021270, P = 6.9 × 10 −9 ), 4q27 in ADAD1 (rs17388568, P = 3.9 × 10 −8 ); and 14q21.1 near FOXA1 and TTC6 (rs1998359, P = 4.8 × 10 −8 ). We identified one locus with substantial evidence of differences in effects across allergies at 6p21.32 in the class II human leukocyte antigen (HLA) region (rs17533090, P = 1.7 × 10 −12 ), which was strongly associated with cat allergy. Our study sheds new light on the shared etiology of immune and autoimmune disease.
Allergies and allergic asthma are among the most common diseases in the industrialized world. In the United States, a nationwide survey found that over half the population tested positive for sensitization to at least one common allergen, showing a considerable increase in prevalence compared to results collected approximately 10 years earlier 1 . The cause of this apparent increase in prevalence is unknown, but the rapidity with which it has occurred implicates an environmental component 2 . Still, estimates of the heritability of allergy are high 3, 4 , suggesting that understanding the genetic liability underlying these conditions is key to understanding disease.
A number of genes implicated in allergy and asthma through association and functional studies belong to pathways involved in immune and inflammatory processes, such as innate immunity, adaptive immunity and allergic inflammation 5 . These genes belong to a range of gene families that encode Toll-like receptors, interleukins, chemokines and various other signaling molecules and transcription factors. Published genome-wide association studies (GWAS) on allergic conditions have focused on asthma and atopic dermatitis, resulting in the identification of a substantial number of loci associated with asthma (HLA-DQB1, IL33, IL18R1, SMAD3, GSDMA, IL2RB, RORA, GSDMB, IL13, SLC22A5, DENND1B, PDE4D, ORMDL3, IL6R, 5q22.1 and 11q13.5) [6] [7] [8] [9] [10] [11] and a smaller number associated with atopic dermatitis (FLG, OVOL1, ACTL9, 5q22.1, 11q13.5 and 20q13.33) [12] [13] [14] . Studies using other measures of atopy have been less definitive, likely owing to limited sample sizes [15] [16] [17] ; the largest study, of allergic rhinitis and immunoglobulin E (IgE) sensitization to grass pollen, identified three regions with genome-wide significant association (the class II HLA region, 5q22.1 and 11q13.5).
We selected three common self-reported allergy phenotypes (pollen allergy, dust-mite allergy and cat allergy) for which comparable data were available in the 23andMe participant cohort 18 and in a cohort of mothers from the Avon Longitudinal Study of Parents and Children (ALSPAC) 19 (Table 1) . We used generalized estimating equations (GEEs) to jointly model genetic effects across all three phenotypes. The GEE approach accounts for correlations between phenotypes and enabled us to estimate both shared and allergy-specific effects. We first performed a genome-wide meta-analysis of GEE tests for shared effects. Then, for a set of 3,725 markers with nominal evidence of association with at least one allergy, we performed GEE tests for allergy-specific effects ( Supplementary Table 1 ).
In the GEE meta-analysis for shared effects across allergies, we identified 16 genome-wide significant loci with association P < 5 × 10 −8 ( Fig. 1, Table 2 and Supplementary Fig. 1 ). Of these, eight had association P < 5 × 10 −8 in the 23andMe cohort and association P < 0.05 in the ALSPAC cohort ( Supplementary Tables 2 and 3) . We identified six loci with suggestive evidence of association (5 × 10 −8 < P < 1 × 10 −6 ) (Supplementary Note). Many of these loci have A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci 9 0 8 VOLUME 45 | NUMBER 8 | AUGUST 2013 Nature GeNetics l e t t e r s previously been associated with other immunity-related phenotypes, and eight have been associated with asthma in previous GWAS (Supplementary Note). Although we describe loci in terms of their proximal genes, in most cases, we have no functional evidence for a specific target, and these variants may affect the regulation of more distant genes.
To ensure that the results were not confounded by age or differences between genotyping platforms, we tested the index SNPs for platform-specific effects and for interactions with age within the 23andMe cohort, but no tests yielded strong evidence of interaction after adjusting for multiple comparisons ( Supplementary Table 4 ). We also tested for pairwise interactions between the 22 loci, but none of these interactions were significant after adjustment for multiple comparisons ( Supplementary Table 5 ).
We assessed whether the identified associations were supported by data from a companion study of allergic sensitization 20 (Table 3 and Supplementary Table 6 ). All 22 loci had effects in the same direction in the 2 studies, and 10 of our 16 genome-wide significant loci were supported with association P < 0.05 in the sensitization study. We also annotated our findings on the basis of linkage disequilibrium (LD) with results from published GWAS, coding variation, monocyte expression quantitative trait loci (eQTLs) 21 and putative regulatory regions identified by the Encyclopedia of DNA Elements (ENCODE) Project ( Table 3 and Supplementary Tables 7-10).
We examined evidence of association in our meta-analysis at other loci previously associated with either asthma or atopic dermatitis ( Supplementary Tables 11 and 12 ). We found nominal support (P < 0.05, consistent risk allele) for seven additional asthma-relevant loci (IL6R, GAB1, RAD50, IL13, IKZF4, RORA and IL2RB), with a false discovery rate (FDR) of 0.04 across these variants. For atopic dermatitis, we found nominal support for associations at five additional loci (IL13, KIF3A, CARD11, MIR1208 and NCF4), with an FDR of 0.07 for this group. These results indicate substantial overlap between these phenotypes, beyond that observed for the loci meeting our criteria for significant and suggestive associations.
To test for allergy-specific genetic effects, we included interaction terms for specific allergies in our GEE models ( Supplementary  Table 1 ). We found one locus with strong evidence of allergy-specific effects on chromosome 6 in the major histocompatibility complex (MHC) region, with the strongest signal 14 kb upstream of HLA-DQA1 ( Fig. 2 and Supplementary Fig. 2 ). Index SNP rs17533090 had combined P = 1.7 × 10 −12 for interaction with allergy type. Effects for the three allergies were consistent across cohorts and indicated that this locus was specifically associated with cat allergy ( Fig. 3) . Of the SNPs listed in Table 2 , only rs2101521 showed evidence of a specific effect favoring cat allergy (unadjusted P = 0.0011), which was weak compared to the evidence for shared effect (P = 5.3 × 10 −21 ).
We performed an exploratory analysis to assess the associations of allergy-associated loci with symptoms of allergic rhinitis, allergic contact dermatitis and allergic asthma in the 23andMe cohort. We reclassified cases on the basis of reported symptoms and used the GEE approach to jointly model genetic effects across symptoms ( Supplementary Tables 13 and 14 ). All effects were in the same direction at all index SNPs. At most loci, we did not see evidence of differential effects across symptoms (P > 0.05 for interaction). One exception was found in GSDMB, where the rs9303280 SNP was most strongly associated with asthma (P = 0.000035 for interaction). Effect sizes for contact dermatitis symptoms tended to be smaller than those for asthma (20/23 loci; P = 0.0004) and rhinitis (18/23 loci; P = 0.007). Effect sizes for asthma tended to be larger than those for rhinitis, but not significantly so (14/23 loci; P = 0.30). However, in association tests, most loci showed more significant association with rhinitis than with asthma (18/23 loci; P = 0.007), with association P values often differing by several orders of magnitude. Thus, although asthma may be a slightly more specific atopy phenotype, rhinitis seems to be more powerful in the discovery of atopy-related loci in cohort studies because it is reported by a much higher proportion of individuals who report allergies.
Genes implicated in our GWAS highlight key pathways in the etiology of common allergy. In the 4p14 region near rs2101521, TLR1 (Toll-like receptor 1) and TLR6 (Toll-like receptor 6) encode patternrecognition receptors whose roles in recognizing external pathogens and activating appropriate immune responses lie at the interface between innate immunity and immunoregulation. Candidate gene Chromosome -log 10 (P value)   5   10   15   20   1  2  3  4  5  6  7  8  9 10 11 12  14  16  18 20 22   TLR1-TLR6-TLR10  TSLP  LRRC32   IL1RL2  HLA-DQB1   MICA  PTGER4  PLCL1  LPP  IL33  NFATC2  GSDMB  SMAD3  GATA3  ADAD1  FOXA1  ZBTB10  ID2 CLEC16A IL4R PEX14 ETS1 Figure 1 Manhattan plot of meta-analysis results for shared effects. The plotted values represent the most significant scores from the meta-analyses of cat, pollen and dust-mite allergy, with all results with association P < 1 × 10 −4 recomputed using GEEs to assess effects shared across allergens. The gray line corresponds to P = 5 × 10 −8 , and results above this threshold are shown in red. Gene labels are provided for cross-referencing with other results and are not intended to suggest that we have established a causal basis for the observed associations. npg l e t t e r s studies have identified associations of TLR genes with asthma [22] [23] [24] , as well as with sensitization to grass and rhinitis 17 . However, this region has not been reported to show significant association in genomewide analyses. We see substantial overlap between loci associated with allergy and loci previously implicated in autoimmune disease. In the 5p13.1 region, index SNP rs7720838 is upstream of PTGER4, encoding prostaglandin E receptor 4, previously implicated as a candidate asthma locus 25 . This SNP is in strong LD (r 2 = 0.94) with rs10440635, which has been associated with ankylosing spondylitis 26 . Variants affecting PTGER4 expression have also been associated with Crohn's disease 27 , and mouse studies point to a role for Ptger4 in the initiation of skin immune responses 28, 29 . In the 2q33.1 region, our eQTL analysis suggested that index SNP rs10497813 was associated with the expression of PLCL1, encoding phospholipase C-like 1, involved in inositol 1,4,5-triphosphate intracellular signaling 30 . Variation in PLCL1 (at rs6738825, r 2 = 0.97 with rs10497813) has also been associated with Crohn's disease 31 .
Several new allergy-associated loci are in or near genes involved in helper T cell differentiation. Index SNP rs9860547 in the 3q28 region falls in the LPP gene (lipoma-preferred partner). A nearby variant in LPP (rs1464510, r 2 = 0.70) has been associated with celiac disease 32, 33 and vitiligo 34 . Our eQTL analysis suggested that our association may be mediated by an effect on the expression of BCL6 (B cell lymphoma 6), a transcription factor that represses the STAT6-mediated response to interleukin (IL)-4 and IL-13 and IgE class switching 35 and inhibits type 2 helper T cell (T H 2) differentiation in a mouse model 36 . In the 20q13.2 region, index SNP rs6021270 is in the NFATC2 gene, encoding a component of the NFAT (nuclear factor of activated T cells) transcription complex, which has an important role in regulating helper T cell differentiation 37 . Variation in NFATC2 has not been associated with any allergic or autoimmune phenotype; however, mice lacking Nfatc2 show increased lung inflammation in experimentally induced allergic asthma 38, 39 . In the 4q27 region, index SNP rs17388568 falls in the ADAD1 gene, but evidence for association spans the nearby IL2 and IL21 genes. This same SNP has been associated with the formation of autoantibodies in type 1 diabetes 40 and with ulcerative colitis 41 , and a nearby SNP in strong LD associated with the inhibition of IL-2 production (rs2069772, r 2 = 0.91) has been suggestively associated with allergic rhinitis 17 . The IL-2 and IL-21 cytokines are involved in the regulation of multiple helper T cell types: IL-21 is upregulated in T H 2 and T H 17 cells, and IL-2 is required for T H 1 differentiation and inhibits the differentiation of T H 17 cells 42 .
In the 14q21.1 region, index SNP rs1998359 is upstream of FOXA1, a member of the forkhead-box transcription factor family. npg l e t t e r s
In mice, the closely related Foxa1 and Foxa2 transcription factors have roles in the regulation of T H 2-mediated inflammation and mucous production in allergic airway disease 43 ; although a similar role for Foxa1 has not been established, Foxa1 and Foxa2 are known to have overlapping patterns of expression in the respiratory epithelium 44 .
In the 6p21.33 region, HLA-B and HLA-C encode major histocompatibility complex (MHC) class I molecules, which are expressed on most cell types and are responsible for the presentation of intracellular peptides to T cells. MICA encodes a protein that belongs to a family of non-classical MHC molecules that resemble the class I molecules and are thought to be involved in innate antitumor and antiviral surveillance 45 . Alleles of HLA-B are associated with severe allergic reactions, such as abacavir hypersensitivity and Stevens-Johnsons syndrome 46, 47 . SNPs in these three genes have been associated with a number of immune system-related phenotypes, such as psoriasis and HIV-1 control 48, 49 .
Previous studies have suggested associations between specific allergen sensitivities and HLA class II alleles 50 . However, these studies have been small and have reported inconsistent results 51 . Our finding of a specific association with cat allergy is the first demonstration to our knowledge of allergen specificity in a GWAS context.
We assessed the directionality of effects in cases where our index SNPs were in strong LD (r 2 > 0.5) with SNPs previously associated with autoimmune disease ( Supplementary Table 15 ). At some loci (LRRC32, PTGER4, PLCL1, SMAD3, ADAD1 and CLEC16A), autoimmune disease and allergy were associated with the same risk alleles. At others (GSDMB and LPP), the risk allele for autoimmune disease seemed to be protective against allergy. Many autoimmune diseases are associated with increased activation of T H 1 responses, whereas allergy has been associated with T H 2 activity 52 . Our results may help to identify elements that influence the balance between T H 1 and T H 2 activity, as well as elements that contribute to both responses.
Self-reported allergy status can be unreliable 53 , and the surveys we used were not standardized or validated. In the 23andMe cohort, the high proportion of allergy cases likely reflects responder bias in completing the allergy survey. The ALSPAC cohort was assessed during pregnancy, which can alter allergic disease status 54 . These limitations should not compromise the validity of our genetic associations, but they make functional interpretation more challenging.
Our results demonstrate that self-reported allergy can be used to identify disease susceptibility loci, with results consistent with studies of more narrowly defined allergy manifestations and allergic sensitization. Self-directed web-based data collection in the 23andMe cohort yielded results largely consistent with those obtained with the traditional survey methods used in the ALSPAC cohort. Our findings reinforce and extend evidence of a shared genetic etiology of allergic and autoimmune disease, with newly discovered susceptibility loci for allergy identified near LPP-BCL6, HLA-C-MICA, PTGER4 and PLCL1, all of which were previously associated with autoimmune disease. Our findings also highlight the role of the T H 2 lineage in the pathogenesis of allergy, with associations identified in or near key T H 2 genes, including ID2, BCL6, GATA3, IL13, IL33, TSLP and IL1RL1. An important next step will be to more carefully characterize the extent to which individual associations lead to a global predisposition to allergy compared to effects on specific target tissues, such as skin, lung or mucosa. 
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Note: Supplementary information is available in the online version of the paper.
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This publication is the work of the authors, and D.A.H., N.J.T. and J.Y.T. will serve as guarantors for the contents of this paper. ONLINe MetHOds 23andMe cohort. Participants in the 23andMe cohort were customers of 23andMe, Inc., a personal genetics company, who had been genotyped as part of the 23andMe Personal Genome Service. Individuals included in the analysis were selected for having >97% European ancestry, as determined through an analysis of local ancestry via comparison to the CEU, YRI and JPT + CHB HapMap 2 populations 55 . A maximal set of unrelated individuals was chosen for the analysis using a segmental identity-by-descent (IBD) estimation algorithm 56 . Individuals were defined as related if they shared more than 700 cM of IBD, including regions where the two individuals shared either one or both genomic segments IBD. This level of relatedness (involving roughly 20% of the genome) corresponds approximately to the minimal expected sharing between first cousins in an outbred population. The study protocol and consent form were approved by the external Association for the Accreditation of Human Research Protection Programs (AAHRPP)-accredited Institutional Review Board, Ethical & Independent Review Services (E&I Review). For a small number of participants (n = 167) under the age of 18 years, consent was provided by a parent, guardian or legally authorized adult. DNA extraction and genotyping were performed on saliva samples by the National Genetics Institute (NGI), a Clinical Laboratory Improvement Amendments (CLIA)-certified clinical laboratory and subsidiary of the Laboratory Corporation of America. Samples were genotyped on one of two platforms. About 35% of the participants were genotyped on the Illumina HumanHap550+ BeadChip platform, which included SNPs from the standard HumanHap550 panel augmented with a custom set of approximately 25,000 SNPs selected by 23andMe. Two slightly different versions of this platform were used, as previously described 18 . The remaining 65% of participants were genotyped on the Illumina HumanOmniExpress+ BeadChip. This platform has a base set of 730,000 SNPs augmented with approximately 250,000 SNPs to obtain a superset of the HumanHap550+ content, as well as a custom set of about 30,000 SNPs. Every sample that did not reach a 98.5% call rate for SNPs on the standard platforms was reanalyzed. Individuals whose analyses repeatedly failed were contacted by 23andMe customer service to provide additional samples.
AUTHoR CoNTRIBUTIoNS
Participant genotype data were imputed against the August 2010 release of the 1000 Genomes Project reference haplotypes 57 . First, we used BEAGLE 58 (version 3.3.1) to phase batches of 8,000 to 9,000 individuals across chromosomal segments of no more than 10,000 genotyped SNPs, with overlaps of 200 SNPs. We excluded SNPs with minor allele frequency (MAF) < 0.001, Hardy-Weinberg equilibrium P < 1 × 10 −20 , call rate < 95% or large allele frequency discrepancies compared to the 1000 Genomes Project reference data. We then assembled fully phased chromosomes by matching the phase of haplotypes across the overlapping segments. We imputed each batch against the European subset of 1000 Genomes Project haplotypes using Minimac 59 (2011-10-27) with 5 rounds and 200 states for parameter estimation. Analyses were limited to 7.4 million SNPs with imputed r 2 > 0.5 averaged across all batches and r 2 > 0.3 in every batch.
23andMe participants were able to fill out web-based questionnaires whenever they logged into their 23andMe accounts. Allergy information was derived primarily from an Allergies and Asthma survey (Supplementary Note). The survey covers allergic reactions to 38 common allergens, including foods, plants, animals, molds, latex, dust mites, medicines and vaccines. Cases were defined as those who reported a positive allergy test, difficulty swallowing or speaking, hives, itchy mouth, itchy eyes, itchy nose or asthma in response to a particular allergen. Controls were defined as individuals who did not meet these criteria. For pollen allergy, we aggregated reports of allergies to grasses, trees or weeds. At the time of the analysis, 30% of 171,274 23andMe research participants had taken this allergy survey. We incorporated 7,635 additional controls who reported having neither seasonal nor environmental allergies in a medical history survey or who reported not currently having allergies in an asthma survey. The final analysis included 46,646 participants. ALSPAC cohort. ALSPAC 19 is a large birth cohort that recruited 14,541 pregnant women resident in Avon, UK, with dates of delivery between 1 April 1991 and 31 December 1992. Mothers enrolled in the study filled out a questionnaire at the end of the third month of pregnancy, which included questions on allergies. Mothers were asked whether they were allergic to cat, pollen or dust, with the option each time of indicating yes or no. The questions did not specify whether an allergy was current or in the past.
The Centre National de Génotypage (CNG) carried out DNA genotyping on the Illumina Human660W-Quad array, and genotypes were called with Illumina GenomeStudio. PLINK 60 (v1.07) was used to carry out quality control measures on an initial set of 10,015 subjects and 557,124 directly genotyped SNPs. SNPs were removed if they had more than 5% missingness or Hardy-Weinberg equilibrium P < 1 × 10 −6 . Additionally, SNPs with MAF of less than 1% were removed. Samples were excluded if they had more than 5% missingness, indeterminate X-chromosome heterozygosity or extreme autosomal heterozygosity. We restricted the analysis to individuals with European ancestry; samples showing evidence of population stratification were identified by multidimensional scaling of genome-wide identity-by-state (IBS) pairwise distances using the CEU, YRI, JPT and CHB HapMap populations as a reference and were then excluded. Cryptic relatedness was defined as a Pi hat value of more than 0.125, which is expected to correspond to roughly 12.5% of alleles being shared IBD or relatedness at a first-cousin level.
A total of 8,340 subjects and 526,688 SNPs passed these quality control filters. We imputed autosomal SNPs against the HapMap 61 CEU population (Utah residents of Northern and Western European ancestry; release 22) using MaCH 62 (v1.0.16). A combination of MaCH and Minimac 59 (v4.4.3, 2010-12-13) was used to impute X-chromosome genotypes against the HapMap CEU population (release 21). Analyses were limited to 2.5 million SNPs with imputed r 2 > 0.3. Out of 8,340 subjects with genotype data, 7,216 had allergy phenotype data and were used in the GWAS.
Ethical approval for the study was obtained from the ALSPAC Law and Ethics Committee and the Local Research Ethics Committees, and written informed consent was provided by all parents.
Single-phenotype GWAS. We performed traditional genome-wide tests for association with each of the three allergy phenotypes using logistic regression, assuming an additive model for genetic effects. The 23andMe analyses were adjusted for age, sex and the top five principal components of the genotype data matrix. The ALSPAC analyses were not adjusted for covariates. ALSPAC GWAS results were remapped to NCBI Build 37 using the liftOver tool 63 . For each allergy phenotype, we used METAL 64 to perform an inverse variance-weighted fixed-effects meta-analysis across 2.4 million SNPs in the intersection of the 23andMe and ALSPAC results. We applied genomic control corrections to the individual GWAS result sets (23andMe: λ = 1.06-1.08; ALSPAC: λ = 1.00-1.02). The meta-analysis results showed no inflation (λ = 1.001-1.004).
Multiple-phenotype GWAS. We jointly modeled association across the three allergens using GEEs 65 . We used an unstructured correlation matrix for the three outcomes. In each cohort, we first fit GEE models with the same covariates used in the single-phenotype GWAS, with additional terms for interactions between each covariate and allergen and a single shared genotype effect, using a fast approximate method 66 . Results were adjusted for genomic control (23andMe: λ = 1.07; ALSPAC: λ = 1.02). We performed an inverse variance-weighted fixed-effects meta-analysis of the shared effects across the 23andMe and ALSPAC cohorts. Then, for a subset of 3,725 SNPs with either single-phenotype association P < 1 × 10 −4 with any allergy or with association P < 1 × 10 −4 in the approximate GEE meta-analysis, we refit GEE models using the R package geepack 67 . In addition to refitting the shared effects, we incorporated interactions between genotype and allergy type and used analysis of deviance to assess the significance of the interactions. We used Fisher's method 68 to compute combined P values from the 23andMe and ALSPAC interaction tests. This test combines interaction evidence in each cohort but does not assess the directional consistency of the interactions.
Heterogeneity assessment. In the 23andMe cohort, we assessed effects from the genotyping platforms by logistic regression of an indicator variable representing the genotyping platform against five principal components and the imputed allele dosage, performing a likelihood ratio test to assess the significance of the allele dosage term. We assessed the index SNPs for age-related effects in the 23andMe cohort by fitting a GEE model with an npg age-by-dosage interaction term and testing the significance of the interaction term with a Wald test. We tested index SNPs for heterogeneity across cohorts using Cochran's Q statistic, and we used I 2 to measure the extent of heterogeneity 69 . We determined confidence intervals for I 2 using the non-central χ 2 method ( Supplementary Table 4 ). Although several SNPs had large I 2 values, confidence intervals were very wide and remained consistent with the null hypothesis of no heterogeneity.
Assessment of SNP interactions.
In the 23andMe cohort, we fit GEE models assuming shared effects across allergy types with allele dosages and interaction terms for all pairwise combinations of the 22 shared-effect index SNPs and rs17533090 ( Supplementary Table 5 ). We used Wald tests to assess the significance of the interaction terms. Given a conditioning SNP 1 and tested SNP 2 , we also computed a joint test of both the main effect of SNP 2 and the interaction SNP 1 × SNP 2 being equal to zero.
Functional annotation. We used publicly available bioinformatics resources to annotate putative associations. In general, we required that an annotated variant be within 500 kb of our index SNP with r 2 > 0.5, based on the European subset of 1000 Genomes Project haplotypes. We used the NCBI Gap Plus resource to identify nearby GWAS findings ( Supplementary Table 7 ). We used tables from the UCSC Genome Browser to identify nearby coding SNPs ( Supplementary Table 8 ). We identified nearby eQTLs from a study of monocytes 21 ( Supplementary Table 9 ). We also used HaploReg 70 to identify nearby annotations from the ENCODE Project 71 ( Supplementary Table 10 ). Finally, we took all reported associations with asthma or atopic dermatitis from the National Human Genome Research Institute (NHGRI) GWAS Catalog 72 and looked up the corresponding results for these loci in our meta-analysis ( Supplementary Tables 11 and 12 ).
Assessment of SNP effects on allergy symptoms.
In the 23andMe cohort, we reclassified cases on the basis of self-reported allergic symptoms representing allergic rhinitis, allergic asthma and/or allergic contact dermatitis (Supplementary Note). We performed a GEE analysis across these multiple outcomes, including the same controls used in the GWAS ( Supplementary  Tables 13 and 14) . The model included the same covariates used in the GWAS (age, sex and five principal components), as well as interactions between these covariates and symptom type.
